Forgione, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 1.964
AS - Asia 1.379
EU - Europa 1.363
SA - Sud America 254
Continente sconosciuto - Info sul continente non disponibili 49
AF - Africa 36
OC - Oceania 7
Totale 5.052
Nazione #
US - Stati Uniti d'America 1.880
SG - Singapore 612
DE - Germania 564
CN - Cina 386
BR - Brasile 200
SE - Svezia 196
FR - Francia 128
VN - Vietnam 94
UA - Ucraina 89
IT - Italia 80
IE - Irlanda 76
GB - Regno Unito 67
JP - Giappone 48
FI - Finlandia 46
ID - Indonesia 44
IN - India 37
TR - Turchia 36
CA - Canada 32
RU - Federazione Russa 30
AR - Argentina 29
BD - Bangladesh 25
PL - Polonia 20
KR - Corea 19
HK - Hong Kong 17
BE - Belgio 16
MX - Messico 14
NL - Olanda 12
IQ - Iraq 11
ZA - Sudafrica 10
CO - Colombia 9
CH - Svizzera 8
IR - Iran 8
AT - Austria 7
EC - Ecuador 7
JM - Giamaica 7
NZ - Nuova Zelanda 6
PK - Pakistan 6
CR - Costa Rica 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EG - Egitto 4
ES - Italia 4
MA - Marocco 4
MY - Malesia 4
PH - Filippine 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
BS - Bahamas 3
DO - Repubblica Dominicana 3
EU - Europa 3
IL - Israele 3
KE - Kenya 3
MD - Moldavia 3
NI - Nicaragua 3
PR - Porto Rico 3
SV - El Salvador 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BZ - Belize 2
CI - Costa d'Avorio 2
CL - Cile 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
LC - Santa Lucia 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
RE - Reunion 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
ML - Mali 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 5.003
Città #
Singapore 316
Ashburn 247
San Jose 194
Chandler 182
Dublin 76
Hefei 71
Chicago 66
Beijing 59
Jacksonville 51
Los Angeles 49
Tukwila 48
San Mateo 47
Tokyo 47
Lauterbourg 45
Jakarta 41
Ann Arbor 40
Marseille 39
Nanjing 38
Ho Chi Minh City 34
New York 34
Nürnberg 34
Council Bluffs 32
Milan 30
Munich 30
Frankfurt am Main 29
Helsinki 25
Izmir 25
Dallas 24
Hanoi 22
Phoenix 22
Woodbridge 22
Boston 21
Kent 19
Moscow 19
Wilmington 19
Dearborn 18
Houston 18
Seoul 18
Princeton 17
Brussels 15
Boardman 14
Hong Kong 14
Santa Clara 14
Kraków 13
São Paulo 13
Atlanta 10
Düsseldorf 10
Shanghai 10
Bremen 9
Nanchang 9
Nuremberg 9
Shenyang 9
Toronto 9
Brasília 8
Redwood City 8
The Dalles 8
Buffalo 7
Manaus 7
Orem 7
Poplar 7
Provo 7
Zhengzhou 7
Auckland 6
Brooklyn 6
Cape Town 6
Denver 6
Fremont 6
Las Vegas 6
North Bergen 6
Paris 6
Rome 6
San Francisco 6
Utrecht 6
Zurich 6
Baghdad 5
Jiaxing 5
Jinan 5
Kunming 5
Leawood 5
Pune 5
Stockholm 5
Tabriz 5
Warsaw 5
Ankara 4
Boydton 4
Charlotte 4
Guangzhou 4
Guarulhos 4
Hangzhou 4
Hebei 4
Medellín 4
Miami 4
Montreal 4
Portland 4
Salvador 4
Tianjin 4
Turku 4
Vienna 4
Washington 4
Baku 3
Totale 2.576
Nome #
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 262
-Hepatic steatosis and vascular disease 250
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 229
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 224
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 216
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 188
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 185
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 182
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 181
-Fatty liver and drugs 177
gastroesophageal reflux disease: facts and uncertaines 162
Tromboembolism and breast cancer: the hidden risk for patient and physician 151
-Nonalcoholic fatty liver disease: defining a common problem 148
Alcoholic and nonalcoholic forms of fatty liver disease. 138
Pattern of macrovascular invasion in hepatocellular carcinoma 131
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. 130
Monofocal hepatocellular carcinoma: How much does size matter? 116
-The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. 109
anticholinergic syndrome due to " Devil's herb': when risks come from the ancient time 105
PREVALENCE OF LIVER STEATOSIS AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 103
Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. 101
Anticholinergic syndrome due to 'Devil's herb': when risks come from the ancient time 99
Genetic and environmental factors responsible for oxidative stress in now alcoholic fatty liver disease (NAFLD) 95
Mild hepatitis at recommended doses of acetaminophen in patients with evidence of constitutionally enhanced cytochrome P450 system activity 95
Body composition and nutrient utilisation in patients with non-alcoholic steato-hepatitis (NASH) 92
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 90
Use of G-CSF during acute on chronic liver failure: Clinical and biochemical safety profile 87
Intestinal permeability in nonalcoholic fatty liver disease (NAFLD) 85
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 84
PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 84
Eighteen needles to forget...an unnamed past 82
CXCR4, vegfr and VLA-4 levels in peripheral blood lymphocytes of patients with acute on chronic liver failure treated with G-CSF 77
G) Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test 75
Thromboembolism and breast cancer: the hidden risk for patient and physician 73
Fibrogenesis and fibrosis in nonalcoholic steatohepatitis 71
FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 68
Quantitative liver function tests to assess MEHOS activity in NASH patients 67
Serum levels of metalloproteinases and their inhibitors in nonalcoholic steatohepatitis 66
C-Methacetin breath test in patients with nonalcoholic steatohepatitis after hypocaloric diet therapy 64
Serum markers of fibrogenesis and fibrosis in nonalcoholic steatohepatitis (NASH) 58
Nonalcoholic-Steatohepatitis (NASH) and hepatic mitochondrial beta-oxidation 52
Totale 5.052
Categoria #
all - tutte 22.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.179


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022137 0 0 0 0 11 4 2 35 3 14 32 36
2022/2023629 53 65 30 81 58 80 53 43 73 51 32 10
2023/2024329 25 118 4 15 28 31 11 4 0 24 36 33
2024/2025710 11 17 66 8 65 23 17 41 107 59 165 131
2025/20261.681 281 71 111 167 281 83 247 82 113 114 73 58
2026/2027447 62 52 107 220 6 0 0 0 0 0 0 0
Totale 5.052